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Since the signal transduction mechanisms responsible for liver regeneration mediated by the plasminogen/plasmin system remain largely
undetermined, we have investigated whether plasmin regulates the pro-apoptotic protein BimEL in primary hepatocytes. Plasmin bound to
hepatocytes in part via its lysine binding sites (LBS). Plasmin also triggered phosphorylation of ERK1/2 without cell detachment. The plasmin-
induced phosphorylation of ERK1/2 was inhibited by the LBS inhibitor epsilon-aminocaproic acid (EACA), the serine protease inhibitor
aprotinin, and the MEK inhibitor PD98059. DFP-inactivated plasmin failed to phosphorylate ERK1/2. Plasmin temporally decreased the
starvation-induced expression of BimEL and activation of caspase-3 via the ERK1/2 signaling pathway, resulting in an enhancement of cell
survival. The amount of mRNA for Bim increased 1 day after the injection of CCl4 in livers of plasminogen knockout (Plg-KO) and the wild-type
(WT) mice. The increase in BimEL protein persisted for at least 7 days post-injection in livers of Plg-KO mice, whereas WT mice showed an
increase in BimEL protein 1 day after the injection. Plg-KO and WT mice showed notable phosphorylation of ERK1/2 7 and 3 days after the
injection of CCl4, respectively. Our data suggest that the plasminogen/plasmin system could decrease BimEL expression via the ERK1/2 signaling
pathway during liver regeneration.
© 2007 Elsevier B.V. All rights reserved.Keywords: Plasmin(ogen); Bim; ERK1/2; Hepatocytes; Signal transduction1. Introduction
Plasmin is generated from its precursor plasminogen which
is synthesized by normal hepatocytes and converted to the two-
chain serine protease plasmin by endogenous tissue-type
plasminogen activator (t-PA) and urokinase-type plasminogen
activator (u-PA) [1]. Plasminogen has five kringle domains at
the N terminus and a serine-protease domain at the C-terminal
end. Lysine binding sites (LBS) present in kringles 1 and 4
display affinity for lysine residues, physiologically relevant for
binding to fibrin and cells, an essential step in fibrinolysis and
pericellular proteolysis [2]. The plasminogen/plasmin system
has multiple physiological/pathophysiological roles, being
involved in thrombolysis, fibrosis, neuronal death, migration,⁎ Corresponding author. Tel.: +81 72 366 0221x3165; fax: +81 72 366 2853.
E-mail address: matsuo-o@med.kindai.ac.jp (O. Matsuo).
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doi:10.1016/j.bbamcr.2007.03.019wound healing, and tissue remodeling, in a variety of tissues
and cells [3,4]. It has been demonstrated that plasmin can
activate several intracellular signaling pathways, including the
phosphatidylinositol 3′-kinase (PI3K) and ERK1/2 pathways
[5–9]. Of note is that plasmin induces the expression of the
growth factor-like gene Cyr61, primary response gene c-fos,
and early growth response gene egr-1 and causes the
proliferation of smooth muscle cells via the ERK1/2 signaling
pathway [5–7,9].
Previous studies have shown that the plasminogen/plasmin
system has extensive roles in the liver. Plasmin may directly
potentiate the proliferation of hepatocytes in primary culture
[10]. In addition, a deficiency in plasminogen led to impaired
hepatic remodeling in mice with carbon tetrachloride (CCl4)-
induced liver injury [11]. Recently, we have shown that
regeneration of the liver was impaired in plasminogen knockout
(Plg-KO) mice whereas it progressed remarkably in alpha2-
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antiplasmin system plays a key role in hepatic regeneration
through the proteolysis of matrix elements and clearance of
cellular debris after liver injury [12]. Thus, plasmin might
contribute to the liver regeneration after injury. Nevertheless,
the signal transduction mechanisms underlying the plasmino-
gen/plasmin system-mediated regeneration remain largely open
to question.
The BH3-only protein Bim, a member of the Bcl-2 family,
promotes apoptosis in several cell types, including lympho-
cytes, neurons, epithelial cells and hepatocytes [13]. In healthy
cells, Bim is bound to cytoplasmic dynein light chain (LC8) and
thereby sequestered to the microtubule-associated dynein motor
complex. Certain apoptotic stimuli disrupt the interaction
between LC8 and the dynein motor complex. Therefore, Bim
localizes to the mitochondria, where it initiates the mitochon-
drial cell death pathway through either the activation of Bax
protein or binding to the pro-survival Bcl-2 family members
[14]. Bim is also rapidly and substantially expressed de novo
following the withdrawal of survival-promoting factors [13,15].
There are three major isoforms of Bim created by alternative
splicing, BimEL, BimL and BimS. Interestingly, BimEL is phos-
phorylated by pro-survival stimuli, such as serum and IL-3, and
then degraded by the ubiquitin/proteasome system [16].
Because the phosphorylation of BimEL could be blocked by
MEK inhibitors or a PI3K inhibitor, activation of the MEK-
ERK and PI3K-Akt pathways attenuates the pro-apoptotic
function of BimEL [16–18].
To clarify further the roles that the plasminogen/plasmin
system plays in liver regeneration, we thus examined if plasmin
could regulate BimEL expression through phosphorylation of
either ERK1/2 or Akt in primary hepatocytes. Here, we provide
evidence that plasmin decreases BimEL levels via activation of
the ERK1/2, but not Akt, signaling pathway in hepatocytes,
resulting in an enhancement of cell survival, during liver
regeneration.
2. Materials and methods
2.1. Animals
The plasminogen knockout (Plg-KO) and wild-type (WT) mice were kindly
provided by Prof. D. Collen (University of Leuven, Belgium) [19]. All exper-
iments were approved by the Institutional Animal Care and Use Committee at
the Kinki University School of Medicine.
2.2. Materials
The human plasmin was purchased from Enzyme Research Laboratories
(South Bend, IN, USA). Collagenase, PD98059, and cycloheximide were from
Sigma (St. Louis, MO, USA). Polyclonal rabbit anti-Bim antibody was obtained
from BD Biosciences Pharmingen (San Jose, CA, USA). p44/42 MAP kinase
antibody, phospho-p44/42 MAP kinase (Thr202/Tyr204) antibody, cleaved
caspase-3 (Asp175) antibody, Akt antibody, phospho-Akt (Ser473) antibody,
and Bad antibody were from Cell Signaling Technology (Beverly, MA, USA).
Aprotinin, diisopropyl fluorophosphate (DFP), carbon tetrachloride (CCl4), corn
oil and protease inhibitor cocktail were purchased from Wako Pure Chemicals
(Osaka, Japan). ε-Aminocaproic acid (EACA) was obtained from Kyowa Hakko
Kogyo (Tokyo, Japan). MG-132 was purchased from Calbiochem (Darmstadt,
Germany). Inhibition of the proteolytic activity of plasmin by DFP was achievedaccording to a previously described method [20]. Excess DFP was removed
by gel filtration and then plasmin's inactivation was confirmed by fibrin
zymography.
2.3. Binding assays using the IAsys biosensor
An IAsys resonant mirror biosensor (Affinity Sensors, Cambridge, UK) was
used to measure the binding of hepatocytes to immobilized plasmin in real time
in vitro. Hepatocytes were isolated from the WT mouse by a method using liver
perfusion with collagenase as described previously [10], and then the cells were
suspended in PBS. Immobilization of proteins and blocking of the free sites on
the cuvette were performed according to previously described methods [21,22].
Briefly, the surface of the carboxylate cuvette was activated using EDC/NHS
[400 mM, N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide and 100 mM, N-
hydroxysuccinimide] and thereafter plasmin, plasminogen, or BSA at 200 μg/ml
was added to the activated carboxylate cuvette. The amount of immobilized
plasmin was about 1.667 ng/mm2. After immobilization, the surface was
blocked with 1 M ethanolamine (pH 8.5) and then washed with 0.1 M glycine–
HCl (pH 3.0) to remove non-coupled protein. All binding experiments were
performed in PBS at 25 °C. The contents of the reaction cuvette were stirred
continuously with the aid of a propeller. The reactions were routinely followed
for 10 min. In inhibition experiments, the cuvette was pre-incubated with
EACA, aprotinin, or DFP for 5 min and then the isolated hepatocytes were
added to the cuvette. After each binding experiment, the cuvette was regenerated
by repeated washes with 0.1 M glycine–HCl (pH 3.0). The data readout from the
biosensor was measured in units of arc-seconds.
2.4. Primary hepatocyte culture
Hepatocytes were isolated from Plg-KO and WT mice by a method using
liver perfusion with collagenase as described above. The isolated hepatocytes
were plated on collagen-coated culture dishes (Iwaki Glass, Chiba, Japan). All
cultures were incubated in a humidified atmosphere of 5% CO2: 95% air at
37 °C. The plated cells were cultured in Williams' medium E (Sigma, MO,
USA) supplemented with 20% FBS (Gibco, NY, USA), 10 nM insulin, 10 nM
glucagon, and 1.6 nM human recombinant epidermal growth factor for 24 h. To
avoid the effect of plasminogen included in the FBS, it was removed by lysine-
sepharose 4B (Amersham Biosciences, Buckinghamshire, UK) before use.
2.5. Detection of BimEL, cleaved caspase-3, and phosphorylated
ERK1/2 and Akt by Western blot analysis in primary hepatocytes
After a pre-culture for 24 h, the medium was replaced with fresh medium
with or without serum and growth factors, and hepatocytes were cultured for
24 h. Then, the hepatocytes cultured in the serum and growth factor free-
medium were stimulated with plasmin at 5 to 50 nM for 5, 15, 30, 60, 120 or
180 min. The cells were also treated with EGF at 50 nM for 15 min. In inhibition
experiments, EACA, aprotinin, and PD98059 were added to the culture medium
24 h, 10 min, and 30 min before the plasmin, respectively. In experiments on
BimEL turnover, hepatocytes were cultured in the serum and growth factor-free
medium for 24 h, and then cycloheximide and MG-132 were added to the
medium 30 min before the plasmin. After aspiration of the medium at scheduled
time points, cells were rinsed with PBS, and lysed in a lysis buffer containing
10 mM sodium phosphate buffer, 150 mM NaCl, 1% Triton X-100, 0.1%
sodium dodecyl sulfate (SDS), 0.5% sodium deoxycholate, 0.2% sodium azide,
and 1% protease inhibitor cocktail (pH 7.2). The cell lysate was harvested and
exposed to freeze–thawing. After vortexing and sonicating, the samples were
centrifuged at 15,000 rpm for 15 min at 4 °C. The concentration of protein in the
supernatant was then determined using a BCA protein assay kit (Pierce,
Rockford, IL, USA). The samples were denatured by heating at 95 °C for 5 min.
Protein samples were separated by electrophoresis on a 10 to 20% SDS-
polyacrylamide gradient gel (Daiichi Pure Chemicals, Tokyo, Japan) and
transferred onto a polyvinylidene difluoride membrane (Immobilon-P; Millipore
Corporation, Billerica, MA). The membrane was blocked with a blocking
solution containing 5% BSA for ERK1/2, phospho-ERK1/2, Akt, and phospho-
Akt or 5% skim milk for Bim and cleaved caspase-3, 137 mM NaCl, 0.1%
Tween 20, and 20 mM Tris–HCl (pH 7.6) for 1 h at room temperature. After
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Tween 20, the membrane was incubated with the primary polyclonal antibodies
at appropriate dilutions with gentle agitation overnight at 4 °C. The primary
antibodies employed were: rabbit anti-p44/42 MAPK antibody (dilution
1:2000), rabbit anti-phospho-p44/42 MAPK (Thr202/Tyr204) antibody
(1:2000), rabbit anti-Akt antibody (1:1000), rabbit anti-phospho-Akt (Ser 473)
antibody (1:1000), rabbit anti-Bim antibody (1:1000), and rabbit anti-cleave
caspase-3 (Asp 175) antibody (1:1000). After incubation with the primary
antibody, the membrane was washed three times with the above-mentioned TBS
solution and then incubated with a horseradish peroxidase-conjugated anti-
rabbit IgG antibody (Zymed Laboratories Inc., South San Francisco, CA) for 1 h
at room temperature. The membrane was washed three times with the TBS
solution again, and positive bands were detected using ECL Plus Western
Blotting Detection Reagents (Amersham Biosciences, Buckinghamshire, UK).
The densities of positive bands were quantified by using a Luminescent image
analyzer (Fuji Photo Film Co., Ltd., Tokyo, Japan). Data on the phosphorylation
of ERK1 are shown relative to ERK1. Data on dephosphorylated BimEL and
cleaved caspase-3 are expressed as a ratio of the density before plasmin
treatment.
2.6. Quantitative measurement of apoptosis in primary hepatocytes
After a pre-culture for 24 h, primary hepatocytes were cultured in fresh
medium with or without serum and growth factors in the presence or absence of
plasmin at 50 nM for 3, 6, 12, 24, or 48 h. Then, the APOPercentage Apoptosis
Assay (Biocolor Ltd., Belfast, Northern Ireland) was used to quantify apoptosis,
according to the manufacturer's instructions [23,24]. The assay uses a dye that
stains red the apoptotic cells undergoing the membrane “flip-flop” event when
phosphatidylserine is translocated to the outer leaflet. Detection of apoptosis can
be readily observed by microscopy. For the quantification of apoptosis, the dye
within the labeled cells can subsequently be released into solution and the
concentration measured at a wavelength of 550 nm, using a color filter
microplate colorimeter.
2.7. Cell viability assay
The viability of primary hepatocytes isolated from Plg-KO and WT mice
was reflected by the activity of mitochondrial dehydrogenases to cleave
tetrazolium salts to produce formazan, using the tetrazolium salt (WST-1) assay.
After a pre-culture for 24 h, hepatocytes were cultured in fresh medium with or
without serum and growth factors in the presence or absence of plasmin at
50 nM for 24 or 48 h. Then, the culture medium was carefully decanted and
hepatocytes were incubated with the premix WST-1 solution (Takara Bio Inc.,
Shiga, Japan) diluted in Hanks' balanced salt solution (1:10, v/v) for 4 h.
Absorbances of the samples were measured against a blank using a microplate
reader at 450 nm with a reference wavelength of 630 nm. In inhibition
experiments, after a change of medium to fresh medium without serum and
growth factors, EACA, aprotinin, or PD98059 was added 60, 10, and 30 min
before plasmin at 50 nM, respectively. Data are expressed as a ratio of cell
viability measured before plasmin treatment.
2.8. Carbon tetrachloride-induced liver injury in mice
Plg-KO and WT mice (18–23 g) received an intraperitoneal administration
of CCl4 solution (25% vol/vol in corn oil) at 2 ml/kg [12]. Under anesthesia with
pentobarbital (50 mg/kg, i.p.), mice were sacrificed by exsanguination, and then
livers were collected before and 1, 3, and 7 days after the injection of CCl4 [12].
The liver samples were stored at −80 °C prior to use.
2.9. Detection of BimEL, Bad, and phosphorylation of ERK1/2 by
Western blot analysis in the mouse liver
The frozen liver was minced in 500 μl of the lysis buffer, using the same
solution described above, and the lysate was sonicated for 10 s on ice. After
centrifugation, the protein concentration of the supernatant was then determined
using the BCA protein assay kit. Western blot analysis of BimEL, Bad, ERK1/2,
and phospho-ERK1/2 was performed as described above. Data on BimEL areexpressed as a ratio of the density before the injection of CCl4. Data on the
phosphorylation of ERK1 are expressed relative to ERK1.
2.10. Analysis of mRNA for Bim by quantitative real time RT-PCR in
mouse liver
Total RNA was isolated from the frozen liver using a Qiagen RNeasy mini
kit (QIAGEN, Hilden, Germany). Then, mRNAwas reverse-transcribed with a
RT reaction kit (Perfect Real Time, Takara Bio Inc., Shiga, Japan) according to
the manufacturer's instructions. Quantitative real-time RT-PCR was assessed by
incorporation of SYBRGreen into double-stranded DNA and performed with an
ABI Prism 7700 Sequence Detection System (Applied Biosystems, Foster, CA).
The PCR primers targeted at mouse Bim were 5′-CGACAGTCTCAGGAG-
GAACC-3′ (forward) and 5′-CCTTCTCCATACCAGACGGA-3′ (reverse)
[25]. The primers for mouse GAPDH were 5′-ATCACTGCCACCCAGAA-
GAC-3′ (forward) and 5′-CACATTGGGGTAGGAACAC-3′ (reverse) [25].
The PCRs for Bim and GAPDH were allowed to proceed for 40 cycles, starting
with a 15-s denaturation period at 95 °C followed by a 60-s annealing and
extending period at 60 °C. The specific mRNA amplification for Bim was
determined as the Ct value followed by normalization with the GAPDH level.
2.11. Statistical analysis
Data are shown as the mean with SEM. Statistical significance was evaluated
by ANOVA followed by Tukey's multiple comparison test or Student's t-test for
two-group data, and was set at a P<0.05 level.3. Results
3.1. Interaction of plasmin and primary hepatocytes
An IAsys resonant mirror biosensor was used to examine the
interaction between plasmin and primary hepatocytes isolated
from WT mice. Hepatocytes bound to immobilized plasmin in a
cell number-dependent manner (Fig. 1A). The binding was
partially blocked by the lysine binding sites (LBS) inhibitor
EACA at 10 mM, but not 10 μM, indicating partial involvement
of the LBS in the binding of plasmin and hepatocytes (Fig. 1B).
Surprisingly, aprotinin, a serine protease inhibitor, at 400 KIU/
ml augmented the binding (Fig. 1C). However, since the effect
of aprotinin, a highly basic protein, might be non-specific, we
examined the effect of the active site inhibitor DFP on the
binding. DFP did not block the binding (Fig. 1D) although it
bound to immobilized plasmin. Hepatocytes also bound to
immobilized plasminogen, and the binding was inhibited by
EACA at 10 mM, implying that the active site of plasmin was
not involved in the binding between plasmin and hepatocytes
(Fig. 1E). Although hepatocytes bound to immobilized BSA, as
a control protein, EACA at 10 mM failed to inhibit the binding
(data not shown). These results suggested that plasmin could
bind to hepatocytes in part via LBS, and its active site did not
contribute to the binding.
3.2. Phosphorylation of ERK1/2, but not Akt, by plasmin in
primary hepatocytes
Plasmin at 50 nM caused a marked phosphorylation of
ERK1/2 at 15 min, which then notably decreased but still
remained at 60 min (Fig. 2A). The plasmin-induced phosphor-
ylation of ERK1/2 was concentration-dependent at 5–50 nM
Fig. 2. Phosphorylation of ERK1/2 after stimulation with plasmin in primary
hepatocytes isolated from WT mice. Hepatocytes were cultured in serum and
growth factor-free medium for 24 h. (A and B) Time-related (A) and
concentration-dependent (B) phosphorylation of ERK1/2 caused by plasmin.
Plasmin was added to the medium at 50 nM for 5–60 min (A) or at 5–50 nM for
15 min (B). (C and D) Effect of the lysine binding site inhibitor EACA at
10 mM, the serine protease inhibitor aprotinin at 400 KIU/ml, and the MEK
inhibitor PD98059 at 50 μM on the phosphorylation of ERK1/2 caused by
plasmin at 50 nM for 15 min. EACA, aprotinin, and PD98059 were added to the
culture medium 24 h, 10 min, and 30 min before the plasmin, respectively. Pla,
plasmin; V, vehicle. (D) Quantification of the phosphorylation of ERK1 in
primary hepatocytes. n=3. ns, not significant. (E) Vehicle (V), plasmin (Pla),
and plasmin with its active site blocked by DFP (DFP-Pla) were added to the
medium at 50 nM for 15 min. Each photograph is representative of at least three
experiments. pERK1/2, phosphorylated ERK1/2.
Fig. 1. (A–D) Binding analysis of plasmin and primary hepatocytes using the
IAsys biosensor. (A) Hepatocytes were added to the cuvette in the indicated
number. (B–D) Effect of the lysine binding site inhibitor EACA (B), serine
protease inhibitor aprotinin (C), and active site inhibitor DFP (D) on the
interaction of immobilized plasmin with primary hepatocytes. Hepatocytes
(2500 cells) were added to the cuvette 5 min after each inhibitor or vehicle. (E)
Binding analysis of plasminogen and hepatocytes using the IAsys biosensor.
Hepatocytes (2500 cells) were added to the cuvette 5 min after EACA or vehicle.
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cell detachment (data not shown). The MEK inhibitor PD98059
at 50 μM completely abolished the phosphorylation of ERK1/2
by plasmin at 50 nM for 15 min (Fig. 2C, D). The plasmin-
induced phosphorylation of ERK1/2 was also significantly
inhibited by either EACA at 10 mM or aprotinin at 400 KIU/ml
(Fig. 2C, D). Plasmin with its active site blocked by DFP could
not trigger phosphorylation of ERK1/2 (Fig. 2E). Plasmin at
50 nM failed to phosphorylate Akt at 5–60 min (Fig. 3A),
although EGF, as a positive control, at 50 nM for 15 min caused
a marked phosphorylation of Akt (Fig. 3B). Phosphorylated Akt
was also detected in hepatocytes cultured with complete
medium (Fig. 3B). These results suggested that plasmin could
activate the ERK1/2, but not Akt, signaling pathway in a
manner dependent on its proteolytic activity and LBS in
primary hepatocytes.
3.3. Down-regulation of BimEL and caspase-3 by plasmin via
the ERK1/2 signaling pathway in primary hepatocytes
Because plasmin could activate the ERK1/2 signaling
pathway, known to promote phosphorylation and proteasome-
dependent degradation of BimEL, a pro-apoptotic protein, we
next examined if plasmin could regulate the expression of
BimEL induced by starvation in primary hepatocytes isolated
from WT mice. When primary hepatocytes were cultured in
serum and growth factor-free medium for 24 h, BimEL exhibitedincreased mobility and expression in a Western blot analysis,
indicating an increase in the amount of dephosphorylated
BimEL (Fig. 4A and B, left). Plasmin at 50 nM for 30 to 60 min
significantly decreased the starvation-induced dephosphoryla-
tion of BimEL, following phosphorylation of ERK1/2, although
the vehicle had no effect (Fig. 4A and B, right). Although
starvation for 3, 6 and 12 h induced phosphorylation of BimEL,
plasmin decreased the level of phosphorylated BimEL
independent of the period of starvation (data not shown).
Starvation for 24 h also increased the amount of cleaved
caspase-3, an active form of caspase-3, following an increase
Fig. 4. (A, left) The starvation induced dephosphorylation of BimEL and
activation of cleaved caspase-3 in primary hepatocytes isolated from WT mice.
Hepatocytes were cultured in complete medium (CM) or serum and growth
factor-free medium (SF) for 24 h. (A, right) Time-related effect of plasmin on the
starvation-induced dephosphorylation of BimEL and activation of caspase-3.
Hepatocytes were cultured in the serum and growth factor-free medium (SF) for
24 h, and then vehicle or plasmin at 50 nM was added to the medium for 30 to
180 min. Each photograph is representative of at least three experiments.
pBimEL, phosphorylated BimEL; de-pBimEL, dephosphorylated BimEL; pERK1/
2, phosphorylated ERK1/2. (B and C) Quantification of dephosphorylated
BimEL (B) and cleaved caspase-3 (C) levels in A. n=3. ns, not significant.
Fig. 3. Plasmin failed to trigger phosphorylation of Akt in primary hepatocytes
isolated from WT mice. (A) Hepatocytes were cultured in serum and growth
factor-free medium for 24 h. Plasmin at 50 nMwas added to the medium for 5 to
60 min. (B) Hepatocytes were cultured in complete medium (CM) or serum and
growth factor-free medium for 24 h. Untreated indicates that hepatocytes were
cultured in serum and growth factor-free medium for 24 h. Vehicle, plasmin at
50 nM, and EGF at 50 nM were added to the serum and growth factor-free
medium for 15 min. Each photograph is representative of at least three
experiments. pAkt, phosphorylated Akt.
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hepatocytes (Fig. 4A and C, left). The increase in the amount
of cleaved caspase-3 was significantly inhibited by plasmin at
50 nM at 30–120 min (Fig. 4A and C, right). These effects of
plasmin were abolished by PD98059 at 50 μM, implying
involvement of the ERK1/2 signaling pathway (Fig. 5).
Since BimEL protein is phosphorylated by pro-survival
stimuli via the ERK1/2 signaling pathway, and then degraded
by the ubiquitin/proteasome system [16], we investigated the
effect of MG-132, a proteasome inhibitor, on the plasmin-
induced decrease in dephosphorylated BimEL. Plasmin at 50 nM
for 3 to 6 h significantly facilitated degradation of BimEL in
primary hepatocytes pretreated with cycloheximide, a protein
synthesis inhibitor (Fig. 6). The effect of plasmin was
completely prevented by MG-132 at 5 μM (Fig. 6). Cyclohex-
imide at 500 ng/ml did not affect the starvation-induced
expression of BimEL (data not shown). These results suggested
that plasmin phosphorylated BimEL via the ERK1/2 signaling
pathway, and then the phosphorylated BimEL was degraded by
the ubiquitin/proteasome system.
3.4. Plasmin protects against the starvation-induced apoptosis
in primary hepatocytes
Since plasmin decreased the expression of BimEL and
caspase-3 via the ERK1/2 signaling pathway, we investigated
whether it could protect against starvation-induced apoptosis in
primary hepatocytes isolated from WT mice. The APOPercen-
tage Apoptosis Assay showed that starvation for 12 h induced
apoptosis in primary hepatocytes (Fig. 7A, B). When hepato-
cytes were cultured with serum and growth factor-free medium
in the presence of plasmin at 50 nM for 12 h, the number of
unlabeled cells increased, implying that plasmin protected
against the starvation-induced apoptosis (Fig. 7C). Plasminexhibited significant cytoprotective effects at 3–48 h when
apoptosis was quantified by measurement of the amount of dye
within the stained cells (Fig. 7D).
3.5. Effect of plasmin on cell survival in primary hepatocytes
Since plasmin decreased the expression of BimEL via ERK1/2
signaling, a pro-survival signaling pathway, we investigated
whether it could enhance cell viability in primary hepatocytes.
When the primary hepatocytes, isolated from WT mice, were
cultured in complete medium, plasmin at 50 nM had no effect on
the viability (Fig. 8A, left). Plasmin at 50 nM also failed to
enhance cell survival when hepatocytes isolated from WT mice
were cultured in the serum and growth factor free-medium for
Fig. 5. Effect of the MEK inhibitor PD98059 at 50 μM on the plasmin-induced
decrease in the dephosphorylated BimEL and activation of caspase-3 in primary
hepatocytes isolated from WT mice. Hepatocytes were cultured in complete
medium (CM) or serum and growth factor-free medium (SF) for 24 h. Plasmin
(Pla) at 50 nM was added to the serum and growth factor-free medium 30 min
after treatment with PD98059 (PD). Hepatocytes were harvested 30 min after the
plasmin was added. Each photograph is representative of at least three
experiments. pERK1/2, phosphorylated ERK1/2; V, vehicle.
Fig. 7. Effect of plasmin on the starvation-induced apoptosis in primary
hepatocytes isolated fromWTmice. The apoptotic cells were stained red with an
APOPercentage Apoptosis Assay kit when phosphatidylserine was translocated
to the outer leaflet. (A) Hepatocytes were cultured in complete medium (CM) for
723N. Kawao et al. / Biochimica et Biophysica Acta 1773 (2007) 718–72724 h (Fig. 8B, left). Then, we next examined the viability and
survival of hepatocytes isolated from Plg-KO mice because
DNA synthesis in primary hepatocytes was inhibited by
tranexamic acid, a LBS inhibitor, or PASI-535, an active site
inhibitor, indicating that plasminogen generated from hepato-
cytes might contribute to cell proliferation [10]. The viability
and survival of hepatocytes isolated from Plg-KOmice tended toFig. 6. Plasmin promoted degradation of BimEL in a proteasome-dependent
manner in primary hepatocytes isolated from WT mice. (A) Hepatocytes were
cultured in serum and growth factor-freemedium for 24 h. Plasmin (Pla) at 50 nM
was added to the medium 30 min after treatment with cycloheximide (CHX) at
500 ng/ml and MG-132 (MG) at 5 μM. Hepatocytes were harvested 0, 3, 6, and
9 h after the plasmin was added. Each photograph is representative of at least
three experiments. pBimEL, phosphorylated BimEL; de-pBimEL, dephosphory-
lated BimEL; pERK1/2, phosphorylated ERK1/2. V, vehicle. (B) Quantification
of dephosphorylated BimEL levels in Fig. 5A. n=3. ns, not significant.
12 h. (B and C) Hepatocytes were cultured in serum and growth factor-free
medium (SF) in the presence or absence of plasmin (Pla) at 50 nM for 12 h.
Arrowheads indicate unlabeled cells. (D) Hepatocytes were cultured in the
complete medium or serum and growth factor-free medium in the presence or
absence of plasmin at 50 nM for 3, 6, 12, 24, or 48 h. For quantification of
apoptosis, the dye within the labeled cells was released into the solution and the
concentration was measured at a wavelength of 550 nm. Values represent the
mean±SEM of seven independent experiments. **P<0.01 vs. SF+V. (For
interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)decrease when vehicle was added to the complete medium (Fig.
8A) or serum and growth factor-free medium (Fig. 8B). Plasmin
at 50 nM did not affect the viability when hepatocytes isolated
from Plg-KO mice were cultured in complete medium (Fig. 8A,
right). Of note is that plasmin at 50 nM significantly enhanced
cell survival when hepatocytes isolated from Plg-KO mice were
cultured in the serum and growth factor-free medium for 24 h
(Fig. 8B). The enhancement of cell survival by plasmin was
abolished by EACA at 10 mM and aprotinin at 400 KIU/ml,
implying involvement of the LBS and proteolytic activity of
plasmin (Fig. 8C). The MEK inhibitor PD98059 at 50 μM also
prevented the plasmin-induced enhancement of cell survival
(Fig. 8C).
3.6. Persistent expression of BimEL after CCl4-induced liver
injury in the plasminogen knockout mouse
We previously reported that WT mice had almost recovered
from liver injury 7 days after the injection of CCl4, although
Plg-KO mice remained in a damaged state until day 14 [12].
Fig. 9. (A) Western blot analysis of BimEL and Bad in livers after the injection of
CCl4. The photograph is representative of at least three experiments. (B)
Quantification of dephosphorylated BimEL levels in livers. n=3. (C) Up-
regulation of mRNA expression for BimEL after CCl4-induced liver injury in
Plg-KO and WT mice, as determined by the quantitative real time RT-PCR
method. n=3–6. ns, not significant.
Fig. 8. (A and B) Viability of hepatocytes cultured in complete medium (A) or
serum and growth factor-free medium (SF) (B) for 24 and 48 h with or without
plasmin at 50 nM. n=8–12. (C) Effect of the lysine binding site inhibitor EACA
at 10 mM, the serine protease inhibitor aprotinin (Apro) at 400 KIU/ml, the
MEK inhibitor PD98059 (PD) at 50 μMon the plasmin-induced enhancement of
cell survival. Hepatocytes isolated from Plg-KO mice were cultured in serum
and growth factor-free medium (SF) for 24 h with or without plasmin at 50 nM.
n=10–12. Data are expressed as the ratio of cell viability measured at day 0. ns,
not significant; V, vehicle.
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induce apoptosis in hepatocytes [26,27], we next investigated
the expression of BimEL after the injection of CCl4 in livers of
Plg-KO and WT mice. The Western blot analysis revealed that
the expression of dephosphorylated BimEL notably increased
1 day post-injection in WT mice, then decreased to the basal
level 7 days post-injection (Fig. 9A). On the other hand,
although the expression of dephosphorylated BimEL increased
1 day after the injection in Plg-KO mice, the up-regulation
lasted for 7 days (Fig. 9A). Seven days after the injection of
CCl4, dephosphorylated BimEL levels significantly increased in
Plg-KO mice, as compared with WT mice (Fig. 9B). The
expression of messenger RNA for Bim markedly increased1 day after the injection of CCl4 in livers of Plg-KO and WT
mice, being more profound in the latter mice (Fig. 9C). The
increase in mRNA expression for Bim had almost returned to
the basal level 7 days post-injection in Plg-KO and WT mice
(Fig. 9C). Another BH-3 only protein Bad slightly increased 3
and 7 days post-injection in Plg-KO and WT mice, although
Plg-KO and WT mice expressed almost the same amount of
Bad after the injection of CCl4 (Fig. 9A). Collectively,
degradation of BimEL would seem to be decreased in Plg-KO
mice after CCl4 induced-liver injury, as compared with that in
WT mice.
3.7. Delayed phosphorylation of ERK1/2 after CCl4–induced
liver injury in the plasminogen knockout mouse
Since plasmin could decrease the starvation-induced expres-
sion of BimEL via activation of the ERK1/2 signaling pathway
(Figs. 4–6), we examined the phosphorylation of ERK1/2 in
Fig. 10. (A) Western blot analysis of phosphorylation of ERK1/2 in livers after
the injection of CCl4. The photograph is representative of at least three
experiments. (B) Quantification of the phosphorylation of ERK1 in livers.
n=7–9. ns, not significant; pERK1/2, phosphorylated ERK1/2.
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Phosphorylation of ERK1/2 was observed 3 days after the
injection in WT mice (Fig. 10A). In contrast, Plg-KO mice
showed phosphorylation of ERK1/2 7 days, but not 3 days,
post-injection (Fig. 10A). Significant differences were detected
in the phosphorylation of ERK1 between the Plg-KO and WT
mice 3 and 7 days after the injection of CCl4 (Fig. 10B).
4. Discussion
The present study demonstrates that plasmin caused the
phosphorylation of ERK1/2, but not Akt, in a manner dependent
on its proteolytic activity and LBS in primary hepatocytes, and
that the starvation-induced expression of BimEL was inhibited
by plasmin through activation of the ERK1/2 signaling pathway
accompanied by cytoprotection and enhancement of cell
survival. We also found that Plg-KO mice showed persistent
expression of BimEL and delayed phosphorylation of ERK1/2 in
liver tissue after the injection of CCl4, as compared with WT
mice.
Plasmin has LBS, consisting of kringle domains, through
which it is able to bind several cell surface proteins, resulting in
the distribution of its proteolytic activity on the pericellular
surface. In the present study, plasmin directly bound to
hepatocytes and caused the phosphorylation of ERK1/2,
known to mediate pro-survival signaling, in primary hepato-
cytes and enhanced the viability of hepatocytes during
starvation (Figs. 1, 2, 8). These effects of plasmin were
abolished by the lysine binding sites inhibitor EACA (Figs. 1, 2,
8). A previous study demonstrated that tranexamic acid, a lysine
binding sites inhibitor, suppressed DNA synthesis in primary
hepatocytes [10]. Moreover, EACA also inhibited the plasmin-induced release of leukotriene B4 in peripheral monocytes [28],
proliferation of smooth muscle cells [7], and gene expression in
fibroblasts [9]. Collectively, it is likely that the plasmin-induced
phosphorylation of ERK1/2 and enhancement of cell survival
require binding to certain proteins expressed on the cell surface
via LBS. A detailed analysis is now in progress in our
laboratory. Majumdar et al. showed that plasmin binds to
integrin α9β1 via kringle domains and simultaneously activates
PAR-1, protease-activated receptor-1, resulting in a facilitation
of migration [29]. Since it is known to be constitutively
expressed in hepatocytes [30], integrin α9β1 might function as a
receptor for plasmin, leading to the activation of GPCRs
[5,9,29,31] and matrix metalloproteases [8,32] and release of
growth factors, such as heparin-binding epidermal growth
factor and basic fibroblast growth factor, from the extracellular
matrix (ECM) [8,33].
It is well established that production of the pro-apoptotic
protein BimEL is induced by serum withdrawal [13,15].
BimEL is also phosphorylated by either the MEK-ERK1/2 or
PI3K-Akt signaling pathway, and then the phosphorylated
BimEL is degraded by ubiquitin/proteasome systems [16–18].
Of special interest is that plasmin decreased the starvation-
induced dephosphorylation of BimEL in the present study
(Fig. 4). In addition, the effect of plasmin was completely
abolished by the MEK inhibitor PD98059 (Fig. 5). Taken
together with the finding that the plasmin-induced degradation
of BimEL was completely blocked by the proteasome inhibitor
MG-132 (Fig. 6), plasmin-induced ERK1/2 signaling con-
tributes to the down-regulation of BimEL expression via the
ubiquitin/proteasome system in hepatocytes. Several reports
demonstrated that PAR-1 triggers activation of the MAP
kinase cascades in various mammalian cells [34,35]. Interest-
ingly, Chalmers et al. showed that a synthesized PAR-1-
activating peptide and the endogenous PAR-1 activator
thrombin inhibit expression of Bim via activation of ERK1/
2 signaling in the fibroblast cell line CCl39 [36]. Collectively,
the PAR-1/ERK1/2 signaling system might be involved in the
plasmin-mediated down-regulation of BimEL expression in
hepatocytes although plasmin could exert its effect in many
ways, such as degradation of the ECM and activation of latent
growth factors and matrix metalloproteases. However, the
significant effect of plasmin on BimEL disappeared after
120 min (Fig. 4A and B, right). Since plasmin is degraded by
its proteolytic activity, the down-regulation of BimEL expression
by plasmin was temporary. In fact, plasmin triggered a marked
phosphorylation of ERK1/2 at 15 min, which then notably
decreased but still remained at 180 min (Figs. 2A and 4A).
Plasmin also partially decreased the starvation-induced activa-
tion of caspase-3 via the ERK1/2 signaling pathway (Figs. 4, 5).
In addition to increasing cell survival (Fig. 8), plasmin could
protect against apoptosis in hepatocytes, in part, inhibiting the
down-regulation of BimEL (Figs. 4, 7). This notion is consistent
with evidence that plasminogen inhibits TNF-alpha-induced
apoptosis in monocytes and the cytoprotective effect requires
proteolytic activity [37]. Although at a concentration of more
than 250 nM, plasmin is known to cause anoikis, a subtype of
apoptosis induced by the detachment of adherent cells from the
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causing the detachment of hepatocytes in the present study (Figs.
7, 8). Plasmin would thus appear to play a different role at the
pericellular surface, being dependent on its local concentration.
The present study demonstrated that starvation caused
apoptotic events, such as expression of BimEL, activation of
caspase-3 (Fig. 4), and alteration of membrane composition
(Fig. 7). However, starvation for 48 h did not decrease cell
survival in hepatocytes isolated from WT mice as evaluated
with the WTS-1 assay (Fig. 8B). The APOPercentage Dye
enters the apoptotic cell following the membrane “flip-flop”
event and its uptake continues until blebbing occurs. Since the
uptake was observed 48 h after starvation although the amount
taken up tended to decrease (Fig. 7), most hepatocytes might
still possess cellular metabolic activity.
CCl4 is known to cause sinusoidal microcirculatory distur-
bance accompanied by fibrosis in liver tissue, and CCl4-induced
liver injury is widely used as a model in studies of hepatic
regeneration [11,12,39]. CCl4 is activated by cytochrome P-450
to form the trichloromethyl radical that reacts with oxygen to
form the trichloromethylperoxy radical, a highly reactive
species. These radicals trigger lipid peroxidation, damage to
DNA, and the release of nitric oxide and several cytokines,
resulting in acute liver injury following necrotic and apoptotic
cell death in hepatocytes [26,27]. BimEL is considered to be
involved in apoptosis caused by serum withdrawal and DNA
damage [40]. Therefore, in the present study, it is likely that the
up-regulation of BimEL expression is caused by the CCl4-
induced sinusoidal microcirculatory disturbance and DNA
damage in hepatocytes. The Western blot and quantitative
real-time RT-PCR analyses showed that the mRNA for BimEL
was degraded more rapidly than the protein in Plg-KO mice, as
compared with WT mice (Fig. 9). Since plasmin could activate
ERK1/2 signaling in primary hepatocytes (Fig. 2), these results
most likely suggest that the signaling pathway for the
degradation of BimEL is diminished in Plg-KO mice. Indeed,
delayed phosphorylation of ERK1/2 was detected by Western
blotting 7 days after the injection of CCl4 in livers of Plg-KO
mice (Fig. 10). Thus, ERK1/2 signaling seems to be important
to the stability of BimEL protein in vivo because BimEL is
phosphorylated by pro-survival stimuli via the ERK1/2
signaling pathway, and then degraded by the ubiquitin/
proteasome system in vitro. We have been shown that the
most severe injury was detected by histological analysis 2 days
after the injection of CCl4 and the injured liver tended to repair
itself about 3 days post-injection in WT mice [12]. Collectively,
these results suggest that plasmin contributes to the activation of
ERK1/2 signaling in the early stages of liver regeneration.
In conclusion, we propose that plasmin could bind to
hepatocytes, at least in part, via LBS and trigger the activation
of ERK1/2 signaling, requiring proteolytic activity. Plasmin
also would decrease the starvation-induced increase in BimEL
and cleaved caspase-3 through activation of ERK1/2 signaling,
in addition to protecting against apoptosis and enhancing cell
survival. Although we found that the expression of BimEL was
temporally induced by toxic injury to the liver, the plasminogen/
plasmin system seems to be involved in the regulation of BimELlevels in the injured liver. The present study thus provides a
novel mechanism for liver regeneration mediated by the
plasminogen/plasmin system.
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